The move marks a turning point in 23andMe’s tumultuous decline. Founded in 2006 by Wojcicki, the company initially gained traction with its saliva-based ancestry kits and went public in 2021. By the ...

Genetic testing company 23andMe is preparing for a renewed auction of its assets after a federal judge agreed to reopen the ...

The sale of genetic testing company 23andMe—which includes genetic data from around 16 million customers—took a new turn at a ...

Civil liberties advocates say the Trump administration's data collection and sharing endanger Americans' constitutional ...

Later this month, the Street will have a fresh opportunity to gauge the potential for Amgen's experimental weight-loss drug, MariTide.